申请人:MITSUBISHI KASEI CORPORATION
公开号:EP0136586A2
公开(公告)日:1985-04-10
Novel corticoid derivatives are disclosed. These derivatives have a strong topical anti-inflammatory activity and extremely weak systemic adverse reactions and are useful for the treatment of acute and chronic eczema, eczema seborrhoicorum, contact dermatitis, atopic dermatitis, psoriasis, asthma, allergic rhinitis, vasomotor rhinitis, hemorrhoids, auditory disorder, ocular disorder, stomatitis, etc.
本研究公开了新型皮质类固醇衍生物。这些衍生物具有很强的局部抗炎活性和极弱的全身不良反应,可用于治疗急慢性湿疹、脂溢性湿疹、接触性皮炎、特应性皮炎、银屑病、哮喘、过敏性鼻炎、血管运动性鼻炎、痔疮、听觉障碍、眼部障碍、口腔炎等。